ENOXAPARIN SODIUM
Generic: ENOXAPARIN SODIUM
BE Pharmaceuticals Inc.Manufacturer
SUBCUTANEOUSRoute
ENOXAPARIN SODIUMActive Substance
2023-06-06Original Approval
ENOXAPARIN SODIUM is FDA application ANDA214646, sponsored by BE PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-01-26
Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous InjectionCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi
Class II2025-08-05
Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefCorrect Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contain
Class III2017-12-05
Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found pack
Top Reported Reactions
1
OFF LABEL USE
1,048 reports
2
DYSPNOEA
996 reports
3
DIARRHOEA
951 reports
4
NAUSEA
942 reports
5
PYREXIA
905 reports
6
ANAEMIA
834 reports
7
VOMITING
796 reports
8
FATIGUE
749 reports
9
THROMBOCYTOPENIA
746 reports
10
PNEUMONIA
697 reports